CorMedix Inc (CRMD NASDAQ) stock market data APIs
$12.2522
0.4(3.3%)
as of June 30, 2025
Try our APIs with
free plan!
CorMedix Inc Financial Data Overview
Price chart is built with
Anychart
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Prev. Close
12.2522
Open
12.6565
High
12.6426
Low
12.174
52 wk Range
3.61-17.43
Market Cap
848 M
P/E Ratio
50
Shares Outstanding
67 825 K
Revenue
82 554 K
EPS
0.2993
Beta
1.608
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CorMedix Inc data using free add-ons & libraries
Get CorMedix Inc Fundamental Data
CorMedix Inc Fundamental data includes:
- Net Revenue: 82 554 K
- EBITDA: 14 923 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-07
- EPS/Forecast: 0.245
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CorMedix Inc News
New
Palantir, Circle Internet Surge Among Monday's Market Cap Stock Movers
Monday’s trading session has seen notable movements in the stock market, with some stocks experiencing significant intra-day volatility. Mega-cap stock Palantir Technologies Inc (NASDAQ:PLTR) has ...
Circle initiated, Disney upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top Upgrades: J...
CorMedix stock rating downgraded to Hold from Buy by D. Boral Capital
Investing.com - D. Boral (OTC:BOALY) Capital downgraded CorMedix (NASDAQ:CRMD) stock rating from Buy to Hold on Monday, following a sharp 24.5% decline in share price over the past week. Despite the r...
Company News for Jun 30, 2025
NIKE Inc.’s (NKE) shares soared 15.2% after the company reported fourth-quarter fiscal 2025adjusted earnings per share of $0.14, surpassing the Zacks Consensus Estimate of $0.12. Shares of Concentri...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
